Company Analysis - Novo Nordisk A/S
RNCOS
January 1, 2012 35 Pages - SKU: CICQ6750140
|
|
Company Analysis assists individual investors, managers and companies in evaluating opportunities, trends, market innovations as well as in selecting appropriate information solutions in order to make effective investment decisions.
The study covers information on the business structure, areas of operation, products and services offered by the company. It comprises SWOT analysis, Key Ratios, and financials that aid investors in gaining an insight into the company's performance.
The report is an outcome of extensive research and makes use of data provided by various credible publications, trade journals, industry associations, and the company sources.
Report Highlights
- Provides a comprehensive version of the company's performance
- Offers key financial data, ratio and SWOT analysis
- Tracks major M&A trends and developments
- Business Profile, SWOT analysis and financial information on top competitors
- View on the company by our analysts
- Supplemented with graphs and tabular information wherever necessary
|
- 1. Company Overview
- 1.1 History
- 1.2 Business Overview
- 1.3 Organizational Structure
- 1.4 Major Mergers & Acquisitions
- 1.5 Ticker Codes at Various Stock Exchange Listings
- 1.6 Management Profile
- 2. Product & Services
- 2.1 Product & Services - An Overview
- 2.2 Revenue Summary by Business Division
- 2.3 Revenue Summary by Geographical Distribution
- 3. Financial Information for the Fiscal Year
- 3.1 Financial Summary for the Fiscal Year
- 3.2 Breakup of Revenue & Sales Trends
- 3.3 Ratio & Market Indicators
- 3.4 Earnings & Income Estimates
- 3.5 Stock Analysis
- 4. SWOT Analysis
- 4.1 Strengths
- 4.2 Weaknesses
- 4.3 Opportunity
- 4.4 Threats
- 5. Top Competitors (Key Financials & SWOT Analysis)
- 5.1 GlaxoSmithKline Plc.
- 5.2 AstraZeneca Plc.
- 5.3 Merck & Co., Inc.
- 5.4 Daiichi Sankyo Company, Limited
- 6. Analyst View
- List of Figures:
- Figure 2-1: Novo Nordisk A/S - Revenue by Business Division (Million US$), 2009 & 2010
- Figure 2-2: Novo Nordisk A/S - Revenue by Geographical Distribution (Million US$), 2009 & 2010
- Figure 3-1: Novo Nordisk A/S - Stock Chart
- List of Tables:
- Table 1-1: Novo Nordisk A/S - Ticker Codes at various Stock Exchange
- Table 1-2: Novo Nordisk A/S - Key Management People
- Table 3-1: Novo Nordisk A/S - Financial Overview (Million US$), 2010
- Table 3-2: Novo Nordisk A/S - Breakup of Revenue & Sales (Million US$), 2008-2010
- Table 3-3: Novo Nordisk A/S - Key Financial Ratios (2008-2010)
- Table 3-4: Novo Nordisk A/S - Earnings and Income Estimates (Million US$), 2008-2010
- Table 5-1: GlaxoSmithKline Plc. - Key Financials (Million US$), 2008-2010
- Table 5-2: GlaxoSmithKline Plc. - SWOT Analysis
- Table 5-3: AstraZeneca Plc. - Key Financials (Million US$), 2008-2010
- Table 5-4: AstraZeneca Plc. - SWOT Analysis
- Table 5-5: Merck & Co., Inc. - Key Financials (Million US$), 2008-2010
- Table 5-6: Merck & Co., Inc. - SWOT Analysis
- Table 5-7: Daiichi Sankyo Company, Limited - Key Financials (Million US$), FY 2009 to FY 2011
- Table 5-8: Daiichi Sankyo Company, Limited - SWOT Analysis
Share this report
Other tasks Related Markets Pharmaceuticals Company Reports Free Alert Me service Receive bi-weekly email alerts on new market research Sign Up Today!
|
